About

About Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. are the US-based indirect subsidiaries of the global healthcare company Otsuka Pharmaceutical Co. Ltd with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka’s US companies share a deep commitment to the development and commercialization of innovative products in the spaces of neuroscience, nephrology, and immunology. At Otsuka, our dedication to patients inspires us to push the boundaries of science to meet the needs of those with complex and immune-mediated kidney diseases. Our persistent pursuit of therapeutic breakthroughs will forever be on their behalf. Otsuka America Pharmaceutical, Inc. (OAPI) is an innovative healthcare company that commercializes Otsuka discovered and in-licensed products in the U.S., with a focus on neuroscience, nephrology, and medical devices. Otsuka America Pharmaceutical, Inc. (OAPI) is an innovative healthcare company that commercializes Otsuka-discovered and in-licensed products in the U.S., with a focus on neuroscience, nephrology, and medical devices. Lundbeck is a global pharmaceutical company, specialized in psychiatric and neurological disorders.